Belimumab Promising for Children with Lupus Nephritis
FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA
FDA Approves Risankizumab-rzaa for PsA
FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA
Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira
FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%
FDA Approves IVIG to Treat Adults with Dermatomyositis
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
- 1
- 2
- 3
- 4
- Next Page »